We are live on ! Find out more
TECX

Tectonic Therapeutic
TECX

63 hedge funds and large institutions have $828M invested in Tectonic Therapeutic in 2018 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more capital invested

Capital invested by funds: $434M → $828M (+$394M)

71% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 17

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

24% more funds holding

Funds holding: 51 → 63 (+12)

0.12% more ownership

Funds ownership: 5.44% → 5.57% (+0.12%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
63
Holders Change
+12
Holders Change %
+23.53%
% of All Funds
1.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
29
Increased
16
Reduced
12
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$14.9M
2
Wells Fargo
Wells Fargo
California
+$13.6M
3
BlackRock
BlackRock
New York
+$13.6M
4
JP Morgan Chase
JP Morgan Chase
New York
+$7.83M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$11.1M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.42M
4
GTC
Ghost Tree Capital
New York
-$6.57M
5
DM
Deerfield Management
New York
-$5.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
CV
1
Clarus Ventures
Massachusetts
$154M – – –
SHI
2
SV Health Investors
Massachusetts
$142M – – –
CAM
3
Cormorant Asset Management
Massachusetts
$77.4M -$554K -1,250 -1%
Citadel Advisors
4
Citadel Advisors
Florida
$77.4M -$11.1M -25,115 -17%
EAM
5
Eventide Asset Management
Massachusetts
$46.4M – – –
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$41.6M +$14.9M +33,502 +101%
JP Morgan Chase
7
JP Morgan Chase
New York
$27.9M +$7.83M +17,654 +65%
FCM
8
Farallon Capital Management
California
$24.1M +$4.12M +9,300 +32%
EA
9
Emerald Advisers
Pennsylvania
$19.6M +$5.12M +11,559 +58%
BlackRock
10
BlackRock
New York
$19.5M +$13.6M +30,606 +4,239%
Wells Fargo
11
Wells Fargo
California
$19.1M +$13.6M +30,629 New
EMFAT
12
Emerald Mutual Fund Advisers Trust
Pennsylvania
$18.8M +$5.56M +12,546 +71%
Millennium Management
13
Millennium Management
New York
$18.2M +$5.17M +11,665 +66%
O
14
OrbiMed
New York
$13M – – –
Vanguard Group
15
Vanguard Group
Pennsylvania
$12.8M +$7.2M +16,229 +375%
DCM
16
Driehaus Capital Management
Illinois
$12M -$2.07M -4,677 -20%
NLVP
17
New Leaf Venture Partners
New York
$8.94M +$826K +1,863 +15%
PAMU
18
Pictet Asset Management (UK)
United Kingdom
$8.83M +$6.29M +14,181 New
PHS
19
PFM Health Sciences
California
$7.73M +$5.5M +12,412 New
Invesco
20
Invesco
Georgia
$7.48M -$266K -600 -5%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$7.15M -$13.4M -30,175 -72%
Wellington Management Group
22
Wellington Management Group
Massachusetts
$6.53M +$804K +1,814 +21%
UBS AM
23
UBS AM
Illinois
$6.35M +$202K +456 +5%
PC
24
PointState Capital
New York
$5.64M -$1.34M -3,020 -25%
AG
25
Artal Group
Luxembourg
$5.19M -$924K -2,084 -20%
1
2 3 4

TECX Hedge Fund Activity: Q3 2018 in Review

63 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q3 2018, worth a combined $828M — up 91% from $434M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TECX positions and 17 closed out — a net gain of 12 holders — while 16 added to existing stakes and 12 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $14.9M. The largest seller was Fidelity Investments, cutting an estimated $13.4M.

  • 63 institutional investors held Tectonic Therapeutic (TECX) as of Q3 2018, up from 51 in Q2 2018.
  • Funds reported $828M of Tectonic Therapeutic stock for Q3 2018, up 91% quarter-over-quarter.
  • 29 funds opened new Tectonic Therapeutic positions in Q3 2018 and 17 closed out, a net change of +12 holders.
  • The largest Tectonic Therapeutic buyer in Q3 2018 was T. Rowe Price Associates, an estimated $14.9M added.
  • The largest Tectonic Therapeutic seller in Q3 2018 was Fidelity Investments, an estimated $13.4M sold.

Based on aggregated 13F filings for Q3 2018.